Center for Drug Evaluation and Research, U.S. Food and Drug Administration, United States
Disclosure information not submitted.
The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of explicit criteria for teratogenicity risk mitigation programs
Monday, August 26, 20241:45 PM – 2:00 PM CEST
The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of Scoring Weights to Prioritize Medications for Risk Management Beyond Labelling
Monday, August 26, 20242:15 PM – 2:30 PM CEST
